|
|
|
|
|
|
|
|
|
|
|
|
|
|
S.B. 333 VETOES
|
|
|
|
|
|
|
|
|
(5) (6) PROMOTE APPROPRIATE AND REAL-TIME, IF FEASIBLE, ACCESS
TO PRESCRIPTION MONITORING DATA BY DISPENSERS AND PRESCRIBERS TO HELP
PREVENT SUBSTANCE ABUSE AND PRESCRIPTION DRUG DIVERSION;
(6) IDENTIFY THE MECHANISM BY WHICH A PRESCRIPTION DRUG IS
IDENTIFIED AS A DRUG OF CONCERN;
(6) DETERMINE A PERIOD OF TIME AFTER WHICH THE INFORMATION
COLLECTED IN THE DATABASE WILL BE DESTROYED;
(7) REQUIRE THE BOARD TO APPLY FOR FEDERAL GRANT MONEY, AS
APPROPRIATE;
(7) (8) ENSURE THAT THE PROGRAM IS DESIGNED TO:
(I) MINIMIZE PREVENT TO THE FULLEST EXTENT POSSIBLE, THE
BURDEN ON DISPENSERS IN THEIR COMPLIANCE WITH THE REQUIREMENTS OF THIS
SUBTITLE; AND
(II) PROMOTE SUBMISSION OF RECEIVE PRESCRIPTION
MONITORING DATA IN A MANNER COMPATIBLE WITH EXISTING DATA SUBMISSION
PRACTICES OF DISPENSERS; AND
(8) (9) ENSURE, TO THE FULLEST EXTENT POSSIBLE, THAT PATIENT
CONFIDENTIALITY IS PROTECTED.
(9) ENSURE THAT:
(I) CONFIDENTIAL OR PRIVILEGED PATIENT INFORMATION IS
KEPT CONFIDENTIAL; AND
(II) RECORDS OR INFORMATION PROTECTED BY THE PRIVILEGE
BETWEEN A HEALTH CARE PROVIDER AND A PATIENT, OR OTHERWISE REQUIRED BY
LAW TO BE HELD CONFIDENTIAL, IS FILED IN A MANNER THAT EXCEPT AS
OTHERWISE PROVIDED IN § 21-2A-06 OF THIS SUBTITLE, DOES NOT DISCLOSE THE
IDENTITY OF THE PERSON PROTECTED.
(E) PRESCRIPTION MONITORING DATA SHALL BE DESTROYED AFTER 2
YEARS, UNLESS A LAW ENFORCEMENT AGENCY OR A HEALTH OCCUPATIONS BOARD
HAS SUBMITTED A WRITTEN REQUEST TO THE DEPARTMENT FOR RETENTION OF
SPECIFIC INFORMATION.
21-2A-03.
(A) THERE IS AN ADVISORY BOARD ON PRESCRIPTION DRUG MONITORING IN
THE DEPARTMENT.
(B) THE BOARD CONSISTS OF THE FOLLOWING 15 20 21 MEMBERS:
(1) THE ATTORNEY GENERAL, OR THE ATTORNEY GENERAL'S DESIGNEE;
(2) THE SECRETARY, OR THE SECRETARY'S DESIGNEE;
|
|
|
|
|
|
|
|
|
- 3024 -
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
